US 11814432
Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof
granted A61KA61K2035/122A61K40/11
Quick answer
US patent 11814432 (Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof) held by SANGAMO THERAPEUTICS FRANCE expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANGAMO THERAPEUTICS FRANCE
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2035/122, A61K40/11, A61K40/22, A61K40/31